The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary results of ZG005, a bispecific antibody targeting PD-1 and TIGIT, in combination with chemotherapy with or without bevacizumab as first-line treatment for advanced cervical cancer.
 
Hanmei Lou
No Relationships to Disclose
 
Shuxia Cheng
No Relationships to Disclose
 
Yun Yan Zhang
No Relationships to Disclose
 
Shihai Liao
No Relationships to Disclose
 
Hui Li
No Relationships to Disclose
 
Xinrao Wu
No Relationships to Disclose
 
Jieqing Zhang
No Relationships to Disclose
 
Huaming Lin
No Relationships to Disclose
 
Yuzhi Li
No Relationships to Disclose
 
Huan Zhou
No Relationships to Disclose
 
Qin Xu
No Relationships to Disclose
 
Haihua Yang
No Relationships to Disclose
 
Hui Zhang
No Relationships to Disclose
 
Linsheng He
No Relationships to Disclose
 
Bingzhong Zhang
No Relationships to Disclose
 
Xin Huang
No Relationships to Disclose
 
Jason Wu
Employment - Suzhou Zelgen Biopharmaceuticals Co., Ltd.
Leadership - Suzhou Zelgen Biopharmaceuticals Co., Ltd.